Latest filing published 14 Aug 2026 for Edgewise Therapeutics, Inc..
Filing timeline
BuySaleInsider track record
John R. Moore: trading record in brief
John R. Moore, listed as board member, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Edgewise Therapeutics, Inc. and Array Biopharma Inc. Over a trading history stretching from 17 February 2006 to 12 August 2026, the count stands at 114 filings.
On the market, this insider has only sold: 54 sales, €5.1M in total. Outside the open market, there are 12 share grants and 47 option exercises. Since January 2026: no purchases and 4 sales on the market.
The record was last updated on 14 August 2026 with an option exercise in Edgewise Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to John R. Moore
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,781 shares0Common StockSEC:0001191702-26-000001:0
- 6,718 shares0Common StockSEC:0001191702-26-000001:1
- 59 shares@ US$44.41420.0001% mcap0.4% of flowCommon StockSEC:0001191702-26-000001:3
- 99 shares@ US$44.50190.0001% mcap0.7% of flowCommon StockSEC:0001191702-26-000001:4
- 2,419 shares@ US$43.79850.0023% mcap17.7% of flowCommon StockSEC:0001191702-26-000001:5
- 2,439 shares@ US$43.80810.0024% mcap17.8% of flowCommon StockSEC:0001191702-26-000001:2
- 2,098 shares@ US$13.390.5% of flowCommon StockSEC:0001562180-25-005799:1
- 5,781 shares0Common StockSEC:0001562180-25-005799:0
- 1,930 shares@ US$16.450.6% of flowCommon StockSEC:0001562180-25-003659:1
- 5,209 shares0Common StockSEC:0001562180-25-003659:0
- 50,000 shares@ US$28.370228.6% of flowCommon StockSEC:0001562180-24-006946:1
- 20,922 shares@ US$0.710.3% of flowCommon StockSEC:0001562180-24-006946:2
- 20,922 shares@ US$27.629511.7% of flowCommon StockSEC:0001562180-24-006946:3
- 50,000 shares@ US$0.716.1% of flowCommon StockSEC:0001562180-24-006946:0
- 1,956 shares@ US$18.910.8% of flowCommon StockSEC:0001562180-24-003830:1
- 5,208 shares0Common StockSEC:0001562180-24-003830:0
- 17,993 shares@ US$20.007.5% of flowCommon StockSEC:0001562180-24-001227:1
- 3,813 shares@ US$1.930.2% of flowCommon StockSEC:0001562180-24-001227:2
- 3,813 shares@ US$20.011.6% of flowCommon StockSEC:0001562180-24-001227:3
- 8,029 shares@ US$1.930.3% of flowCommon StockSEC:0001562180-24-001227:4
- 8,029 shares@ US$20.013.4% of flowCommon StockSEC:0001562180-24-001227:5
- 17,993 shares@ US$1.936.2% of flowCommon StockSEC:0001562180-24-001227:0
- 8,497 shares@ US$10.5015.6% of flowCommon StockSEC:0001562180-23-008572:0
- 1,897 shares@ US$8.900.3% of flowCommon StockSEC:0001562180-23-003922:1
- 5,208 shares0Common StockSEC:0001562180-23-003922:0
25 of 114 declarations
